DK0546548T3 - Guanidinalkyl-1,1-biphosphonsyrederivater, fremgangsmåde til deres fremstilling og deres anvendelse - Google Patents

Guanidinalkyl-1,1-biphosphonsyrederivater, fremgangsmåde til deres fremstilling og deres anvendelse

Info

Publication number
DK0546548T3
DK0546548T3 DK92121077.9T DK92121077T DK0546548T3 DK 0546548 T3 DK0546548 T3 DK 0546548T3 DK 92121077 T DK92121077 T DK 92121077T DK 0546548 T3 DK0546548 T3 DK 0546548T3
Authority
DK
Denmark
Prior art keywords
preparation
alkyl
hydrogen atom
chemical structure
acid derivatives
Prior art date
Application number
DK92121077.9T
Other languages
Danish (da)
English (en)
Inventor
Anne-Marie Moura
Hans-Jochen Dr Lang
Christoph Dr Naumann
Denis Carniato
Ryochi Satoh
Masakazu Katoh
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0546548T3 publication Critical patent/DK0546548T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025Esters of poly(thio)phosphonic acids
    • C07F9/405Esters of poly(thio)phosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92121077.9T 1991-12-12 1992-12-10 Guanidinalkyl-1,1-biphosphonsyrederivater, fremgangsmåde til deres fremstilling og deres anvendelse DK0546548T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4140908 1991-12-12
DE4211976 1992-04-09

Publications (1)

Publication Number Publication Date
DK0546548T3 true DK0546548T3 (da) 1997-10-13

Family

ID=25910001

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92121077.9T DK0546548T3 (da) 1991-12-12 1992-12-10 Guanidinalkyl-1,1-biphosphonsyrederivater, fremgangsmåde til deres fremstilling og deres anvendelse

Country Status (16)

Country Link
US (1) US5294608A (pl)
EP (1) EP0546548B1 (pl)
JP (1) JP3377234B2 (pl)
KR (1) KR100269544B1 (pl)
AT (1) ATE152453T1 (pl)
AU (1) AU657018B2 (pl)
BR (1) BR9204984A (pl)
CA (1) CA2085171C (pl)
DE (1) DE59208426D1 (pl)
DK (1) DK0546548T3 (pl)
ES (1) ES2101012T3 (pl)
FI (1) FI105550B (pl)
MX (1) MX9207215A (pl)
NZ (1) NZ245414A (pl)
RU (1) RU2124519C1 (pl)
TW (1) TW222637B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
GB8922026D0 (en) * 1989-09-29 1989-11-15 Pharma Mar Sa Novel anti-viral and cytotoxic agent
DE4223940A1 (de) * 1992-07-21 1994-01-27 Boehringer Mannheim Gmbh Neue acyclische Amidingruppen-haltige Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
ATE176476T1 (de) * 1992-12-02 1999-02-15 Hoechst Ag Guanidinalkyl-1, 1-bisphosphonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung
JPH06298779A (ja) * 1993-04-15 1994-10-25 Hoechst Japan Ltd ヘテロ環イミノビスメチレンビスホスホン酸誘導体
US5854227A (en) * 1994-03-04 1998-12-29 Hartmann; John F. Therapeutic derivatives of diphosphonates
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
ES2210728T3 (es) 1997-03-07 2004-07-01 Metabasis Therapeutics, Inc. Nuevos inhibidores bencimidazol de la fructosa-1, 6-bifosfatasa.
WO1998039344A1 (en) * 1997-03-07 1998-09-11 Metabasis Therapeutics, Inc. Novel purine inhibitors of fructose-1,6-bisphosphatase
IT1303672B1 (it) 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei
JP2003519183A (ja) * 2000-01-04 2003-06-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 心臓および動脈の石灰化を抑制する低用量ビスホスホネートの使用
US8012949B2 (en) * 2004-10-08 2011-09-06 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
WO2006039721A2 (en) * 2004-10-08 2006-04-13 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
EP2001486A4 (en) * 2006-03-17 2010-12-29 Univ Illinois BIPHOSPHONATE COMPOUNDS AND CORRESPONDING METHODS
US7457149B2 (en) 2006-05-05 2008-11-25 Macronix International Co., Ltd. Methods and apparatus for thermally assisted programming of a magnetic memory device
AU2008240266A1 (en) * 2007-04-12 2008-10-23 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225469A1 (de) * 1982-07-05 1984-01-05 Schering AG, 1000 Berlin und 4709 Bergkamen Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
DE3770982D1 (de) * 1986-04-24 1991-08-01 Fujisawa Pharmaceutical Co Diphosphonsaeure-verbindungen, verfahren zu deren herstellung und sie enthaltende arzneimittel.
KR880011136A (ko) * 1987-03-11 1988-10-26 모리오까 시게오 아졸- 아미노메틸렌 비스포스폰산 유도체
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
US4990503A (en) * 1988-08-12 1991-02-05 Yamanouchi Pharmaceutical Co., Ltd. Heterocyclic bisphosphonic acid derivatives

Also Published As

Publication number Publication date
BR9204984A (pt) 1993-06-15
TW222637B (pl) 1994-04-21
AU657018B2 (en) 1995-02-23
KR100269544B1 (ko) 2000-10-16
CA2085171C (en) 2003-12-02
RU2124519C1 (ru) 1999-01-10
ES2101012T3 (es) 1997-07-01
EP0546548B1 (de) 1997-05-02
US5294608A (en) 1994-03-15
EP0546548A1 (de) 1993-06-16
CA2085171A1 (en) 1993-06-13
NZ245414A (en) 1995-04-27
DE59208426D1 (de) 1997-06-05
MX9207215A (es) 1993-06-01
FI925617A0 (fi) 1992-12-10
FI105550B (fi) 2000-09-15
JP3377234B2 (ja) 2003-02-17
ATE152453T1 (de) 1997-05-15
FI925617A (fi) 1993-06-13
AU3017392A (en) 1993-06-17
JPH05271260A (ja) 1993-10-19

Similar Documents

Publication Publication Date Title
DK0546548T3 (da) Guanidinalkyl-1,1-biphosphonsyrederivater, fremgangsmåde til deres fremstilling og deres anvendelse
ES443725A1 (es) Metodo para producir un producto hipotensor.
AR034268A1 (es) Compuestos derivados de piperidina, su uso en preparacion de medicamentos, composicion farmaceutica, metodo de tratamiento y proceso para su preparacion
NO963066D0 (no) Substituerte 3-aryliden-7-azaoksindolforbindelser og fremgangsmåte for deres fremstilling
DK139287A (da) Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler
NZ240050A (en) Substituted piperazine derivatives; pharmaceutical compositions and preparatory processes
ES309169A1 (es) Un procedimiento para la preparacion de derivados benzodiazepinicos.
ES448475A1 (es) Procedimiento de preparacion de derivados triyodados del benceno.
DK55584D0 (da) Hidtil ukendte carbacykliner,fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
ES269967A1 (es) Un procedimiento para la preparaciën de pirazolonas sustituidas
ES503837A0 (es) Procedimiento para la preparacion de 3,1-benzoxazin-2-onas
DK0498718T3 (da) Anvendelse af 4-(3-trifluormethylphenyl)-1,2,3,6-tetrahydropyridinderivater som indfangere af frie radikaler
NO864665D0 (no) Nye basisk substituerte pyridinforbindelser, fremgangsmaate til deres fremstilling, legemiddel inneholdende dem, og deres anvendelse.
DK0991650T3 (da) Nye N-benzensulfonyl-L-prolin-forbindelser, deres fremstilling og deres anvendelse til terapeutiske formål
ES8100282A1 (es) Procedimiento para la obtencion de nuevos derivados de la piperacina metanimina
DK104388D0 (da) Hidtil ukendte 2-(2,3-dihydro-2-oxo-3-benzofuranyl)-eddikesyrederivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
NO992870D0 (no) Difenylalkyl-tetrahydropyridiner, fremgangsmÕter for deres fremstilling og farmas°ytiske blandinger inneholdende dem
DE69323998D1 (de) Pharmazeutisch aktive flavilium verbindungen
JO1648B1 (en) Nitrogen compounds
DK104488A (da) Acetamider afledt af 2,3-dihydro-3-phenyl-2-benzofuranon, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem
NO20010332L (no) Nye derivater av 6-deoksyerytromycin, deres fremstillingsprosess og deres anvendelse som medikamenter
DK0871611T3 (da) Hidtil ukendte glycylanilidderivater, deres fremstilling og deres terapeutiske anvendelse
DK523482A (da) Oximer af 3'''-dehydro-kardenolid-tridigitoxosider, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
FI934016A (fi) Foerfarande foer framstaellning av terapeutiskt aktiva kinolin- eller naftyridinkarboxylsyraderivat som innehaoller en spirosubstituent
ES271160A2 (es) Procedimiento para la preparación de amino-norcanfanderivados n-substituidos